Brian Selby

Brian Selby has extensive experience as a finance professional in the biopharmaceutical and software industries. Brian started their career in 2000 as a Corporate Controller at Genomica Corporation, a Nasdaq listed software company. Brian played a key role in the company's successful IPO and was involved in the acquisition transition team when the company was acquired in 2001.

In 2002, they joined Source Precision Medicine, Inc. as a Corporate Controller, where they were responsible for managing financial operations. Brian then moved to Silver Creek Systems in 2003, taking up a similar role as a Corporate Controller.

In 2004, Brian joined Myogen, Inc. as a Corporate Controller. Myogen was a Nasdaq listed biopharmaceutical company focused on cardiovascular therapeutics. Brian played a pivotal role in the company's acquisition by Gilead Sciences for $2.5 billion in 2006.

Brian continued their journey with ARCA biopharma, Inc. in 2007, taking up the position of Corporate Controller. Brian held this role until 2014 before transitioning to the position of Vice President Finance & Chief Accounting Officer in 2015. Details regarding the start and end dates of this role are not provided.

Overall, Brian Selby's work experience demonstrates their expertise in financial management, particularly in the biopharmaceutical and software industries.

Brian Selby has a Master of Science Degree in Business Administration & Accounting from the University of Colorado Denver. Brian also holds a Bachelor of Science (B.S.) in Business Finance & Real Estate from Colorado State University. Additionally, Brian is a Certified Public Accountant, although details about the institution, month, and year of obtaining the certification are not provided.